Status:
WITHDRAWN
EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
Lead Sponsor:
EarlySense Ltd.
Collaborating Sponsors:
The Chaim Sheba Medical Center
Conditions:
COPD Patients
Eligibility:
All Genders
18+ years
Brief Summary
Continuous measurement of breathing patterns, heart rate, restlessness and cough in sleep using EarlySense ES 16 device. Predicting worsening in COPD patients' condition using the above parameters.
Detailed Description
Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department. During the study the patients' breathing patterns, heart rate, res...
Eligibility Criteria
Inclusion
- CHF, COPD and Pneumonia Patients or control group non respiratory patients
- 18 years old and up
- Able to perform spirometry test or connect to ECG, respiratory belt, SPO2
- Willing to sign consent form
- Home close to Tel Aviv
Exclusion
- hospitalization within the passing year
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00361426
Start Date
January 1 2008
End Date
February 1 2009
Last Update
July 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaim Sheba Medical Center
Ramat Gan, Israel